Rockville, MD, United States of America

Dror I Baruch


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dror I Baruch: Innovator in Malaria Research

Introduction

Dror I Baruch is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of malaria research, particularly through his innovative work on the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). His research focuses on understanding the mechanisms of adhesion of parasitized red blood cells, which is crucial for developing effective treatments and diagnostics for malaria.

Latest Patents

Dror I Baruch holds a patent titled "Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A." This invention relates to the discovery of a var gene and corresponding protein that modulates the adhesion of parasitized red blood cells to chondroitin sulfate A. The patent also discloses novel biological tools, prophylactics, therapeutics, diagnostics, and methods of use related to this discovery.

Career Highlights

Dror I Baruch is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to contribute to groundbreaking research in the field of infectious diseases, particularly malaria.

Collaborations

Throughout his career, Dror I Baruch has collaborated with notable colleagues, including Artur Scherf and Louis H Miller. These collaborations have further enhanced the impact of his research and innovations in the scientific community.

Conclusion

Dror I Baruch is a key figure in malaria research, with a focus on the mechanisms of red blood cell adhesion. His patent and work at the National Institutes of Health highlight his commitment to advancing our understanding of malaria and developing new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…